British Association of Dermatologists' guidelines on the efficacy and use of acitretin in dermatology

Ormerod AD, Campalani E, Goodfield MJD. Br J Dermatol 2010; 162: 952-963.

Available via doi:10.1111/j.1365-2133.2010.09755.x

• Acitretin audit standards
• Acitretin PIL

British Association of Dermatologists’ guidelines for care of patients with actinic keratosis 2017

D. de Berker, J.M. McGregor, M.F. Mohd Mustapa, L.S. Exton and B.R. Hughes.  Br J Dermatol 2017, 176: 20-43

Available via doi:10.1111/bjd.15107

• Actinic keratoses PIL

British Association of Dermatologists' guidelines for the management of alopecia areata 2012

Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. Br J Dermatol 2012; 166: 916-926.

Available via doi:10.1111/j.1365-2133.2012.10955.x

• Alopecia areata audit standards
• Alopecia areata PIL

British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011

Meggitt SJ, Anstey AV, Mohd Mustapa MF, Reynolds NJ, Wakelin S. Br J Dermatol 2011; 165; 711-734.

Available via doi:10.1111/j.1365-2133.2011.10575.x

• Azathioprine audit standards
• Azathioprine PIL

Guidelines for the management of basal cell carcinoma

Telfer NR, Colver GB, Morton CA. Br J Dermatol 2008; 159: 35-48.

Available via doi:10.1111/j.1365-2133.2008.08666.x

• Basal cell carcinoma audit standards
• Basal Cell Carcinoma PIL

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update

C.H. Smith, Z.Z.N. Yiu, T. Bale, A.D. Burden, L.C. Coates, W. Edwards, E. MacMahon, S.K. Mahil, A. McGuire, R. Murphy, C. Nelson-Piercy, C.M. Owen, R. Parslew, O.A. Uthman, R.T. Woolf, L. Manounah, M.C. Ezejimofor, L.S. Exton, M.F. Mohd Mustapa, on behalf of the British Association of Dermatologists' Clinical Standards Unit. Br J Dermatol 2020; 183 (4) 6328-637.

Available via doi: 10.1111/bjd.19039

• Decision Aid
• Psoriasis Area and Severity Index (PASI)
• Dermatology Life Quality Index (DLQI)
• Psoriasis Epidemiology Screening Tool (PEST)
• UK Biologics Checklist May 2014
• BAD position statement on biosimilars 2017

British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012

Venning VA, Taghipour K, Mohd Mustapa MF, Highet AS, Kirtschig G. Br J Dermatol 2012; 167: 1200-1214.

Available via doi:10.1111/bjd.12072

• Bullous pemphigoid audit standards
• Bullous pemphigoid audit proforma
• Pemphigoid PIL

British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018

Berth-Jones J, Exton LS, Ladoyanni E, Mohd Mustapa MF, Tebbs VM, Yesudian PD, Levell NJ. Br J Dermatol. 2019 Jun;180(6):1312-1338.

Available via doi:10.1111/bjd.17587

• Ciclosporin PIL

British Association of Dermatologists’ guidelines for the management of contact dermatitis 2017

G.A. Johnston, L.S. Exton, M.F. Mohd Mustapa, J.A. Slack, I.H. Coulson, J.S.C. English and J.F. Bourke JF. Br J Dermatol 2017; 176: 317-329.

Available via doi:10.1111/bjd.15239

ECRI Trust Scorecard - requires registration (free) for access

• Contact dermatitis PIL
• Hand dermatitis - how to care for your hands PIL

British Association of Dermatologists' guidelines for the management of cutaneous warts 2014

Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. Br J Dermatol 2014; 171; 696-712.

Available via doi:10.1111/bjd.13310

• Cutaneous viral warts audit standards
• Plantar warts PIL

British Association of Dermatologists’ guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis 2018

G.W.M. Millington, A. Collins, C.R. Lovell, T.A. Leslie, A.S.W. Yong, J.D. Morgan, T. Ajithkumar, M.J. Andrews, S.M. Rushbook, R.R. Coelho, S.J. Catten, K.Y.C. Lee, A.M. Skellett, A.G. Affleck, L.S. Exton, M.F. Mohd Mustapa, N.J. Levell. Br J Dermatol 2018; 178: 34–60.

Available via: doi:10.1111/bjd.16117

British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018.

Ingram JR, Collier F, Brown D, Burton T, Burton J, Chin MF, Desai N, Goodacre TEE, Piguet V, Pink AE, Exton LS, Mohd Mustapa MF. Br J Dermatol. 2019 May;180(5):1009-1017.

Available via: doi: 10.1111/bjd.17537

ECRI Trust Scorecard - requires registration (free) for access

• Hidradenitis suppurativa PIL

Hydroxychloroquine and chloroqine retinopathy: recommendations on screening.

London: The Royal College of Ophthalmologists, 2018.

https://www.rcophth.ac.uk/wp-content/uploads/2018/03/Hydroxychloroquine-and-Chloroquine-Retinopathy-Screening-Guideline-and-Recommendations.pdf

• Hydroxychloroquine PIL

Advice on the safe introduction and continued use of isotretinoin in acne in the UK 2010

Goodfield MJD, Cox NH, Bowser A, McMillan JC, Millard LG, Simpson NB, Ormerod AD. Br J Dermatol 2010; 162: 1172-1179.

Available via doi:0.1111/j.1365-2133.2010.09836.x

• Isotretinoin audit standards
• Isotretinoin audit proforma
• Isotretinoin PIL

British Association of Dermatologists' guidelines for the management of lichen sclerosus 2018.

Lewis FM, Tatnall FM, Velangi SS, Bunker CB, Kumar A, Brackenbury F, Mohd Mustapa MF and Exton LS. Br J Dermatol 2018; 178: 839-853.

Available via doi:10.1111/bjd.16241

ECRI Trust Scorecard - requires registration (free) for access

• Lichen sclerosus guidelines 2018 Journal club slides
• Lichen sclerosus PIL (female)
• Lichen sclerosus PIL (male)

Revised U.K. guidelines for the management of cutaneous melanoma 2010.

Marsden JR, Newton-Bishop JA, Burrows L, Cook M, Corrie PG, Cox NH, Gore ME, Lorigan P, MacKie R, Nathan P, Peach H, Powell B, Walker C. Br J Dermatol 2010; 163: 238-256.

“The British Association of Dermatologists decided not to update this guideline (see Archive Clinical Guidelines page) due to the publication of the National Institute for Health and Care Research (NICE) guideline Melanoma: assessment and management (NG14)”

• Melanoma audit standards
• Melanoma stage 1A PIL
• Melanoma stage 1B PIL
• Melanoma stage 2 PIL
• Melanoma stage 3 PIL
• Melanoma stage 4 PIL

The prevention, diagnosis, referral and management of melanoma of the skin: conise guidelines

Newton Bishop J, Bataille V, Gavin A, Lens M, Marsden J, Mathews T, Ormerod A, Wheelhouse C, Royal College of Physicians, British Association of Dermatologists. Concise guidance to good practice series, no. 7. London: RCP, 2007.

The chair of the melanoma guidelines group reviewed the guidelines in July 2012 and decided that no update was necessary

• Melanoma guidelines 2007

British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016

Warren R.B., Weatherhead S.C., Smith C.H., Exton L.S., Mohd Mustapa M.F., Kirby B., Yesudian P.D. Br J Dermatol 2016; 175: 23-44.

Available via doi:10.1111/bjd.14816

• Methotrexate checklist
• Methotrexate guidelines corrigendum - PIIINP unit
• Methotrexate PIL

Diagnosis, management and prevention of occulational contact dermatitis: concise guidelines.

Royal College of Physicians, British Association of Dermatologists, British Occupational Health Research Foundation, Faculty of Occupational Medicine, Health and Work Development Unit, NHS Plus. Concise guidance to good practice series, no 13. London: RCP, April 2011.

• Occupational contact dermatitis guidelines 2011

 British Association of Dermatologists' guidelines for the management of onychomycosis 2014

Ameen M, Lear JT, Madan V, Mohd Mustapa MF, Richardson M. Br J Dermatol 2014; 171: 937-58.

Available via doi:10.1111/bjd.13358

• Fungal infections of the nails PIL

British Association of Dermatologists guidelines for the management of pemphigus vulgaris 2017

Harman KE, Brown D, Exton LS, Groves RW, Hampton PJ, Mohd Mustapa MF, Setterfield J, Yesudian PD. Br J Dermatol 2017; 177: 1170-1201.

Available via doi: 10.1111/bjd.15930

• Supplementary information (administration of rituximab)
• Pemphigus vulgaris audit standards
• Pemphigus vulgaris PIL

British Association of Dermatologists and British photodermatology Group guidelines for topical photodynamic therapy (PDT) 2018

Wong TH, Morton CA,Collier N, Haylett A, Ibbotson S, McKenna KE, Mallipeedi R, Moseley H, Seukeran DC, Rhodes LE, Ward KE, Mohd Mustapa MF, Exton LS.. Br J Dermatol 2019; 180; 730-739.

Available via doi:10.1111/bjd.17309

ECRI Trust Scorecard - requires registration (free) for access

• Photodynamic therapy PIL

 Guidelines on the measurement of ultraviolet radiation levels in ultraviolet phototherapy: report issued by the British Association of Dermatologists and British Photodermatology Group 2015

Moseley H, Allan D, Amatiello H, Coleman A, du Peloux Menagé H, Edwards C, Exton LS, Ferguson J, Garibaldinos T, Martin C, Mohd Mustapa MF. Br J Dermatol 2015; 173: 333-350.

Available via doi:10.1111/bjd.13937

• Phototherapy PIL

British Association of Dermatologists and U.K. Curaneous Lymphoma Group (CLG) guidelines for the management of primary cutaneous lymphomas 2018

Gilson D, Whittaker SJ, Child FJ, Scarisbrick JJ, Illidge TM, Parry EJ, Mohd Mustapa MF, Exton LS, Kanfer E, Rezvani K, Dearden CE, Morris SL. Br J Dermatol 2019;180: 496-526.

Available via doi: 10.1111/bjd.17240.

• Mycosis fungoides PIL

British Association of Dermatologists' and British Photodermatology Group guidelines for the safe and effective use of PUVA therapy 2015.

Ling TC, Clayton TH, Crawley J, Exton LS, Goulden V, Ibbotson S, McKenna K, Mohd Mustapa MF, Rhodes LE, Sarkany R, Dawe RS. Br J Dermatol 2016; 174: 24-55.

Available via doi:10.1111/bjd.14317

• Phototherapy PIL

Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma 2009.

Motley RJ, Preston PW, Lawrence CM - update of the original guideline which appeared in Br J Dermatol 2002; 146: 18-25.

• Squamous cell carcinoma guidelines 2009
• Squamous cell carcinoma audit standards
• Squamous cell carcinoma PIL

British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014

Morton CA, Birnie AJ, Eedy DJ. Br J Dermatol 2014; 170: 245-260.

Available via doi:10.1111/bjd.12766

• Bowen's disease (SCC in situ) audit standards
• Bowen's disease (SCC in situ) PIL
• SCC in situ audit proforma

UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016

Creamer D, Walsh SA , Dziewulski P, Exton LS, Lee HY, Dart JKG, Setterfield J,  Bunker CB, Ardern-Jones MR, Watson KMT, Wong GAE, Philippidou M, Vercueil A,  Martin RV, Williams G, Shah M, Brown D, Williams P, Mohd Mustapa MF, Smith CH. Br J Dermatol 2016; 174: 1194-1227.

This is a dual publication in the British Journal of Dermatology available via doi:10.1111/bjd.14530 and Journal of Plastic, Aesthetic and Reconstructive Surgery.

• SJS/TEN Pathway of Care
• SJS/TEN summary of treatment (2 pages)
• SJS/TEN discharge letter - template
• SJS/TEN PIL
• SJS/TEN audit standards

British Association of Dermatologists guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people 2018

McPherson T, Exton LS, Biswas S, Creamer D, Dziewulski P, Newell L, Tabor KL, Wali GN, Young AE, Mohd Mustapa MF, Murphy. R Br J Dermatol 2019; 181: 37-54.

Available via doi 10.1111/bjd.17841

ECRI Trust Scorecard - requires registration (free) for access

• Paediatric SJS-TEN pathway of care
• SJS-TEN paediatrics discharge letter -TEMPLATE
• SJS/TEN PIL

British Association of Dermatologists' guidelines for the management of tinea capitis 2014

Fuller LC, Barton RC, Mohd Mustapa MF, Proudfoot LE, Punjabi SP, Higgins EM. Br J Dermatol 2014. 171: 454-63.

Available via doi:10.1111/bjd.13196

• Tinea capitis audit standards
• Tinea capitis PIL
• Tinea capitis audit proforma

Guidelines for evaluation and management of urticaria in adults and children

Grattan CEH, Humphreys FY. Br J Dermatol 2007; 157: 1116-1123.

Available via doi:10.1111/j.1365-2133.2007.08283.x

• Urticaria and angioedema audit standards
• Urticaria and angioedema PIL

 Guidelines for the management and diagnosis of vitiligo.

Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J, Young K. BrJ Dermatol 2008; 159; 1051-1076.

Available via doi:10.1111/j.1365-2133.2008.08881.x

• The natural history of vitiligo
• The Quality of Life in patients with vitiligo compared to other skin diseases
• The accuracy of scoring index
• The efficacy of applying betamethasone, clobestasol, flucinolone, fluticasone, or mometasone vs. placebo
• The efficacy of applying calcipotroiol or tacalcitol vs. placebo
• The efficacy of applying tacrolimus or pimecrolimus vs. placebo
• The efficacy of applying p-(benzyloxy)phenol (hydroquinone monobenzyl ether) vs. placebo
• The efficacy of a course of narrow-band UVB (including high intensity light sources) vs. placebo
• The efficacy of a course of narrow-band UVB with a vitamin D analogue vs. narrow-band UVB with placebo
• The efficacy of systemic (i.e. orally and parenterally administered) treatments, including corticosteroids, ciclosporin and other immunosuppressive agents
• The efficacy of a skin graft and of various forms of placebo
• The efficacy of cognitive therapy vs. psychological support or no treatment
• Vitiligo PIL